Differences in coronary risk factors, procedural characteristics, mortality and stent thrombosis between two all-comers percutaneous coronary intervention registries from Europe and Japan: A patient-level data analysis of the Bern-Rotterdam and j-Cypher registries

EuroIntervention

Volumn 11, Issue 5, 2015, Pages 533-540

  Onuma, Yoshinobu ^a   Kimura, Takeshi ^b   Räber, Lorenz ^c   Magro, Michael ^a   Girasis, Chrisafios ^a   Van Domburg, Ron ^a   Windecker, Stephan ^c   Mitsudo, Kazuaki ^d   Serruys, Patrick W ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b KYOTO UNIVERSITY   (Japan)

^c UNIVERSITY OF BERN   (Switzerland)

^d Kurashiki Chuou Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; THIENOPYRIDINE DERIVATIVE;

ADULT; AGE; AGED; ARTICLE; BODY MASS; CARDIOGENIC SHOCK; CONTROLLED STUDY; CORONARY RISK; DIABETES MELLITUS; FEMALE; GENDER; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; IMPLANTATION; INCIDENCE; JAPAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; NETHERLANDS; PERCUTANEOUS CORONARY INTERVENTION; REGISTER; SAPHENOUS VEIN GRAFT; SIROLIMUS ELUTING CORONARY STENT; SMOKING; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; STENT THROMBOSIS; SWITZERLAND; ACUTE CORONARY SYNDROME; CLINICAL TRIAL; CORONARY THROMBOSIS; DRUG ELUTING STENT; GRAFT OCCLUSION, VASCULAR; MIDDLE AGED; MULTICENTER STUDY; MYOCARDIAL INFARCTION; PROSTHESIS FAILURE; RISK FACTOR; STATISTICS AND NUMERICAL DATA;

ACUTE CORONARY SYNDROME; AGE FACTORS; AGED; CORONARY THROMBOSIS; DIABETES MELLITUS; DRUG-ELUTING STENTS; FEMALE; GRAFT OCCLUSION, VASCULAR; HUMANS; HYPERTENSION; JAPAN; MALE; MIDDLE AGED; MORTALITY; MYOCARDIAL INFARCTION; NETHERLANDS; PERCUTANEOUS CORONARY INTERVENTION; PROSTHESIS FAILURE; REGISTRIES; RISK FACTORS; SMOKING; SWITZERLAND;

EID: 84976311748     PISSN: 1774024X     EISSN: 19696213     Source Type: Journal    
DOI: 10.4244/EIJY14M06_09     Document Type: Article

References (25)

1. Holmes DR Jr, Kereiakes DJ, Garg S, Serruys PW, Dehmer GJ, Ellis SG, Williams DO, Kimura T, Moliterno DJ. Stent thrombosis. J Am Coll Cardiol. 2010;56:1357-65.
2. Wenaweser P, Daemen J, Zwahlen M, van Domburg R, Jüni P, Vaina S, Hellige G, Tsuchida K, Morger C, Boersma E, Kukreja N, Meier B, Serruys PW, Windecker S. Incidence and correlates of drug-eluting stent thrombosis in routine clinical practice. 4-year results from a large 2-institutional cohort study. J Am Coll Cardiol. 2008;52:1134-40.
3. Daemen J, Wenaweser P, Tsuchida K, Abrecht L, Vaina S, Morger C, Kukreja N, Jüni P, Sianos G, Hellige G, van Domburg RT, Hess OM, Boersma E, Meier B, Windecker S, Serruys PW. Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study. Lancet. 2007;369:667-78.
4. Ong AT, Hoye A, Aoki J, van Mieghem CA, Rodriguez Granillo GA, Sonnenschein K, Regar E, McFadden EP, Sianos G, van der Giessen WJ, de Jaegere PP, de Feyter P, van Domburg RT, Serruys PW. Thirty-day incidence and six-month clinical outcome of thrombotic stent occlusion after bare-metal, sirolimus, or paclitaxel stent implantation. J Am Coll Cardiol. 2005;45:947-53.
5. Sarkees ML, Bavry AA, Galla JM, Bhatt DL. Bare metal stent thrombosis 13 years after implantation. Cardiovasc Revasc Med. 2009;10:58-9.
6. Doyle B, Rihal CS, O'Sullivan CJ, Lennon RJ, Wiste HJ, Bell M, Bresnahan J, Holmes DR Jr. Outcomes of stent thrombosis and restenosis during extended follow-up of patients treated with bare-metal coronary stents. Circulation. 2007;116:2391-8.
7. McFadden EP, Stabile E, Regar E, Cheneau E, Ong AT, Kinnaird T, Suddath WO, Weissman NJ, Torguson R, Kent KM, Pichard AD, Satler LF, Waksman R, Serruys PW. Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy. Lancet. 2004;364:1519-21.
8. Serruys PW, Ong AT, van Herwerden LA, Sousa JE, Jatene A, Bonnier JJ, Schonberger JP, Buller N, Bonser R, Disco C, Backx B, Hugenholtz PG, Firth BG, Unger F. Five-year outcomes after coronary stenting versus bypass surgery for the treatment of multivessel disease: the final analysis of the Arterial Revascularization Therapies Study (ARTS) randomized trial. J Am Coll Cardiol. 2005;46:575-81.
9. Serruys PW, Lemos PA, van Hout BA; Arterial Revascularisation Therapies Study part II Steering Committee and Investigators. Sirolimus eluting stent implantation for patients with multivessel disease: rationale for the Arterial Revascularisation Therapies Study part II (ARTS II). Heart. 2004;90:995-8.
10. Kimura T, Morimoto T, Nakagawa Y, Tamura T, Kadota K, Yasumoto H, Nishikawa H, Hiasa Y, Muramatsu T, Meguro T, Inoue N, Honda H, Hayashi Y, Miyazaki S, Oshima S, Honda T, Shiode N, Namura M, Sone T, Nobuyoshi M, Kita T, Mitsudo K; j-Cypher Registry Investigators. Antiplatelet therapy and stent thrombosis after sirolimus-eluting stent implantation. Circulation. 2009;119:987-95.
11. Park SJ, Park DW, Kim YH, Kang SJ, Lee SW, Lee CW, Han KH, Park SW, Yun SC, Lee SG, Rha SW, Seong IW, Jeong MH, Hur SH, Lee NH, Yoon J, Yang JY, Lee BK, Choi YJ, Chung WS, Lim DS, Cheong SS, Kim KS, Chae JK, Nah DY, Jeon DS, Seung KB, Jang JS, Park HS, Lee K. Duration of dual antiplatelet therapy after implantation of drug-eluting stents. N Engl J Med. 2010;362:1374-82.
12. Cutlip DE, Nakazawa G, Krucoff MW, Vorpahl M, Mehran R, Finn AV, Vranckx P, Kimmelstiel C, Berger C, Petersen JL, Palabrica T, Virmani R. Autopsy validation study of the academic research consortium stent thrombosis definition. JACC Cardiovasc Interv. 2011;4:554-9.
13. Ong AT, McFadden EP, Regar E, de Jaegere PP, van Domburg RT, Serruys PW. Late angiographic stent thrombosis (LAST) events with drug-eluting stents. J Am Coll Cardiol. 2005;45:2088-92.
14. Braunwald E, Antman EM, Beasley JW, Califf RM, Cheitlin MD, Hochman JS, Jones RH, Kereiakes D, Kupersmith J, Levin TN, Pepine CJ, Schaeffer JW, Smith EE 3rd, Steward DE, Theroux P, Gibbons RJ, Alpert JS, Eagle KA, Faxon DP, Fuster V, Gardner TJ, Gregoratos G, Russell RO, Smith SC Jr. ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction: executive summary and recommendations. A report of the American College of Cardiology/American Heart Association task force on practice guidelines (committee on the management of patients with unstable angina). Circulation. 2000;102:1193-209.
15. Kohsaka S, Goto M, Nagai T, Lee VV, Elayda M, Furukawa Y, Fukushima M, Komeda M, Sakata R, Ohsugi M, Fukuda K, Wilson JM, Kita T, Kimura T. Impact of diabetes among revascularized patients in Japan and the U.S. Diabetes Care. 2012;35:654-9.
16. Kohsaka S, Kimura T, Goto M, Lee VV, Elayda M, Furukawa Y, Fukushima M, Komeda M, Sakata R, Willerson JT, Wilson JM, Kita T. Difference in patient profiles and outcomes in Japanese versus American patients undergoing coronary revascularization (collaborative study by CREDO-Kyoto and the Texas Heart Institute Research Database). Am J Cardiol. 2010;105:1698-704.
17. Onuma Y, Kukreja N, Ramcharitar S, Hochadel M, Gitt A, Serruys P. Interventional treatment in diabetics in the era of drugeluting stents and compliance to the ESC guidelines: lessons learned from the Euro Heart Survey Programme. EuroIntervention. 2009;4:578-87.
18. Ramcharitar S, Hochadel M, Gaster AL, Onuma Y, Gitt A, Serruys PW. An insight into the current use of drug eluting stents in acute and elective percutaneous coronary interventions in Europe. A report on the EuroPCI Survey. EuroIntervention. 2008;3:429-41.
19. Guidelines for application of elective percutaneous coronary intervention (and bypass grafting) in patients with coronary artery disease. http://www.j-circ.or.jp/guideline/pdf/JCS2000-fujiwara-h.pdf
20. Gaku N, Kengo T, Aoki J, Onuma Y, Yamamoto H, Higashikuni Y, Nakajima H, Hara K. Clinical and angiographic outcomes of sirolimus-eluting stents implantation in Japanese patients in daily practice. Circ J. 2006;70:1367-71.
21. Tunstall-Pedoe H, Kuulasmaa K, Amouyel P, Arveiler D, Rajakangas AM, Pajak A. Myocardial infarction and coronary deaths in the World Health Organization MONICA Project. Registration procedures, event rates, and case-fatality rates in 38 populations from 21 countries in four continents. Circulation. 1994;90:583-612.
22. STATLINE CBvdS. Population; sex, age, marital status, origin and generation. http://statline.cbs.nl/StatWeb/publication/?DM=SLEN&PA=37325eng&D1=0&D2=0&D3=0&D4=0&D5=0-1,84,102,139,145,210,225&D6=a&LA=EN&HDR=G2,G3,G4,T&STB=G1,G5&VW=T.
23. BFS. Ausländerinnen und Ausländer in der Schweiz - Bericht 2008. http://www.bfs.admin.ch/bfs/portal/de/index/news/publikationen.html?publicationID=3403
24. Kimura T, Morimoto T, Nakagawa Y, Kawai K, Miyazaki S, Muramatsu T, Shiode N, Namura M, Sone T, Oshima S, Nishikawa H, Hiasa Y, Hayashi Y, Nobuyoshi M, Mitudo K; j-Cypher Registry Investigators. Very late stent thrombosis and late target lesion revascularization after sirolimus-eluting stent implantation: five-year outcome of the j-Cypher Registry. Circulation. 2012;125:584-91.
25. Raber L, Magro M, Stefanini GG, Kalesan B, van Domburg RT, Onuma Y, Wenaweser P, Daemen J, Meier B, Jüni P, Serruys PW, Windecker S. Very late coronary stent thrombosis of a newer-generation everolimus-eluting stent compared with earlygeneration drug-eluting stents: a prospective cohort study. Circulation. 2012;125:1110-21.